Synapse - Kenneth Yu

Results (54)

A phase 1/1B trial of ADI-PEG 20 plus nab-paclitaxel and gemcitabine in patients with advanced pancreatic adenocarcinoma

Journal Article

Lowery, M. A.; Yu, K. H.; Kelsen, D. P.; Harding, J. J.; Bomalaski, J. S.; Glassman, D. C.; Covington, C. M.; Brenner, R.; Hollywood, E.; Barba, A.; more...
Cancer (2017)

Fulltext@MSK | Save

Stereotactic body radiation vs. intensity-modulated radiation for unresectable pancreatic cancer

Journal Article

Park, J. J.; Hajj, C.; Reyngold, M.; Shi, W.; Zhang, Z.; Cuaron, J. J.; Crane, C. H.; O’Reilly, E. M.; Lowery, M. A.; Yu, K. H.; more...
Acta Oncologica (2017)

Fulltext@MSK | Save

Do pancreatic cancer (PDA) stem cell markers predict biologic behavior?

Meeting Abstract

Sahin, I. H.; Turkekul, M.; Capanu, M.; Askan, G.; McMahon, B.; Yu, K. H.; Lowery, M. A.; Basturk, O.; Iacobuzio-Donahue, C.; O'Reilly, E. M.
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Phase 1B trial of ADI-PEG 20 (A) plus nab-paclitaxel (nab-P) and gemcitabine (gem) in subjects with advanced pancreatic cancer (APC)

Meeting Abstract

Lowery, M. A.; Capanu, M.; Glassman, D. C.; Covington, C. M.; Gluskin, J.; Brenner, R.; Li, C. F.; Bomalaski, J. S.; Johnston, A.; Barba, A.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Pancreas adenocarcinoma: Ascites, clinical manifestations, and management implications

Journal Article

Hicks, A. M.; Chou, J.; Capanu, M.; Lowery, M. A.; Yu, K. H.; O'Reilly, E. M.
Clinical Colorectal Cancer (2016)

Fulltext@MSK | Save

Presentation, clinical behavior, outcomes and therapies for patients with advanced pancreas adenocarcinoma (PAC) who present with or develop ascites

Meeting Abstract

Hicks, A. M.; O'Reilly, E. M.; Capanu, M.; Lowery, M. A.; Yu, K. H.
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Treatment, outcomes, and clinical trial participation in elderly patients with metastatic pancreas adenocarcinoma

Journal Article

Li, D.; Capanu, M.; Yu, K. H.; Lowery, M. A.; Kelsen, D. P.; O'Reilly, E. M.
Clinical Colorectal Cancer (2015)

Fulltext@MSK | Save

Phase II trial of veliparib (V) in patients (pts) with previously treated BRCA or PALB2-mutated (mut) pancreas adenocarcinoma (PC)

Meeting Abstract

Lowery, M. A.; Kelsen, D. P.; Smith, S. C.; Moore, M.; Kindler, H. L.; Golan, T.; Segal, A.; Hollywood, E.; Maynard, H.; Capanu, M.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Phase IB trial of cisplatin (C), gemcitabine (G), and veliparib (V) in patients with known or potential BRCA or PALB2-mutated pancreas adenocarcinoma (PC)